KCNQ4 | Potassium voltage-gated channel, KQT-like subfamily, member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
KCNS1 | Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 1 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNS2 | Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 2 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNS3 | Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3 | Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNT2 | Potassium channel, subfamily T, member 2 | Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
LBP | Lipopolysaccharide binding protein | Plasma proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
LHFPL5 | Lipoma HMGIC fusion partner-like 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
LRRC8A | Leucine rich repeat containing 8 family, member A | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
LRRC8B | Leucine rich repeat containing 8 family, member B | Predicted membrane proteins Transporters
| | | | | Mixed |
LRRC8C | Leucine rich repeat containing 8 family, member C | Predicted membrane proteins Transporters
| | | | | Mixed |
LRRC8D | Leucine rich repeat containing 8 family, member D | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
LRRC8E | Leucine rich repeat containing 8 family, member E | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
MARVELD3 | MARVEL domain containing 3 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
MCL1 | Myeloid cell leukemia 1 | Cancer-related genes Mitochondrial proteins Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
MCOLN1 | Mucolipin 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Expressed in all |
MCOLN2 | Mucolipin 2 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
MMD | Monocyte to macrophage differentiation-associated | Predicted membrane proteins Transporters
| | | | | Expressed in all |
MS4A1 | Membrane-spanning 4-domains, subfamily A, member 1 | CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
MS4A10 | Membrane-spanning 4-domains, subfamily A, member 10 | Predicted membrane proteins Transporters
| | | | | Group enriched |
MS4A14 | Membrane-spanning 4-domains, subfamily A, member 14 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
MYADM | Myeloid-associated differentiation marker | Predicted membrane proteins Transporters
| | | | | Expressed in all |
NALCN | Sodium leak channel, non-selective | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
NPPC | Natriuretic peptide C | Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
NSF | N-ethylmaleimide-sensitive factor | Enzymes Predicted intracellular proteins Transporters
| | | | | Tissue enriched |
ORAI1 | ORAI calcium release-activated calcium modulator 1 | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
ORAI3 | ORAI calcium release-activated calcium modulator 3 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
P2RX3 | Purinergic receptor P2X, ligand-gated ion channel, 3 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
P2RX4 | Purinergic receptor P2X, ligand-gated ion channel, 4 | Predicted membrane proteins Transporters
| | | | | Mixed |
P2RX7 | Purinergic receptor P2X, ligand-gated ion channel, 7 | Predicted membrane proteins Transporters
| | | | | Mixed |
PANX1 | Pannexin 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
PANX2 | Pannexin 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
PANX3 | Pannexin 3 | Predicted membrane proteins Transporters
| | | | | Not detected |
PCDH15 | Protocadherin-related 15 | Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
PDYN | Prodynorphin | Disease related genes Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
PENK | Proenkephalin | Plasma proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
PIEZO1 | Piezo-type mechanosensitive ion channel component 1 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
PIEZO2 | Piezo-type mechanosensitive ion channel component 2 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
PKD1 | Polycystic kidney disease 1 (autosomal dominant) | Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
PKD1L1 | Polycystic kidney disease 1 like 1 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Mixed |
PKD1L3 | Polycystic kidney disease 1-like 3 | Predicted membrane proteins Transporters
| | | | | Not detected |
PKD2 | Polycystic kidney disease 2 (autosomal dominant) | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Expressed in all |
PKD2L1 | Polycystic kidney disease 2-like 1 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
PLN | Phospholamban | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
PLP2 | Proteolipid protein 2 (colonic epithelium-enriched) | Predicted membrane proteins Transporters
| | | | | Expressed in all |
PLTP | Phospholipid transfer protein | Plasma proteins Predicted intracellular proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
PON1 | Paraoxonase 1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
PSAP | Prosaposin | Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Expressed in all |
PSEN1 | Presenilin 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
PSEN2 | Presenilin 2 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
PXMP4 | Peroxisomal membrane protein 4, 24kDa | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |